This list is an analysis based on recent market events. It's not an investment recommendation.
About
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
What is Translational Development Acquisition stock price today?▼
The current price of TDAC is $10.85 USD — it has increased by +0.24% in the past 24 hours. Watch Translational Development Acquisition stock price performance more closely on the chart.
What is Translational Development Acquisition stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Translational Development Acquisition stocks are traded under the ticker TDAC.
Is Translational Development Acquisition stock price growing?▼
TDAC stock has risen by +0.05% compared to the previous week, the month change is a +0.99% rise, over the last year Translational Development Acquisition has showed a +4.99% increase.
What is Translational Development Acquisition market cap?▼
Today Translational Development Acquisition has the market capitalization of 209.42M
What were Translational Development Acquisition earnings last quarter?▼
TDAC earnings for the last quarter are -0.23 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Translational Development Acquisition have?▼
As of August 27, 2026, the company has 2 employees.
In which sector is Translational Development Acquisition located?▼
Translational Development Acquisition operates in the Finance & Payments sector.
When did Translational Development Acquisition complete a stock split?▼
Translational Development Acquisition has not had any recent stock splits.
Where is Translational Development Acquisition headquartered?▼
Translational Development Acquisition is headquartered in NEW YORK, United States.